Investigating retinal vessel leakage in cerebral small vessel disease
Official title: Retinal Vessel Leakage in Cerebral Small Vessel Disease: a Sub-study of the Mild Stroke Study 3
Run by University of Edinburgh · NCT06416371 · Data updated 2026-11-12
This study is trying to see if leaking blood vessels in the eyes can help us understand how serious cerebral small vessel disease is in people who have had mild strokes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Edinburgh Academic / other |
| Locations | 1 site (Edinburgh) |
| Status | Recruiting |
| Started | January 13, 2025 |
| Main results expected | February 15, 2029 |
| Study ends | February 15, 2029 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT06416371 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals who are part of the Mild Stroke Study 3 cohort and have had a contrast-enhanced MRI within the last 12 months.
✕Probably not a fit
Patients with conditions known to cause retinal leakage or severe dementia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the occurrence of leakage from retinal vessels in patients with cerebral small vessel disease (SVD). Using fluorescein angiography, participants will be assessed for retinal vessel leakage, which may correlate with the severity of their SVD. The study will recruit individuals from the Mild Stroke Study 3 cohort who have previously undergone brain scans and other evaluations. The findings could provide insights into the pathogenesis of SVD and offer a cost-effective alternative to MRI for monitoring disease progression.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and monitoring of cerebral small vessel disease through retinal imaging.
How similar studies have gone: While the approach of using retinal imaging in this context is innovative, similar studies have shown promise in linking retinal health to cerebral vascular conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Membership in the Mild Stroke Study 3 cohort * Contrast enhanced MRI within 12 months * Clear optical media in both eyes, as assessed by study investigator * Best corrected visual acuity (near vision) ≥N36 Exclusion Criteria: * Any condition known to cause retinal leakage (i.e., worse than background diabetic retinopathy, retinal vein occlusion, active uveitis, wet age-related macular degeneration, malignant hypertension) * Previous treatment for retinal leakage (retinal laser, intravitreal anti-VEGF) * Recent eye surgery * Shallow anterior chambers as assessed by torch test * Pregnancy, renal failure * Severe dementia * Known allergy to fluorescein * History of allergy such as food or drug induced urticaria or history of bronchial asthma * Any other severe or acute medical or psychiatric conditions * Inability to give informed consent
Where it's running
-
NHS Lothian
Edinburgh, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital Dementia Registry Bavaria: a multicenter, long-term registry of people with mild cognitive impairment and dementia and their family caregivers
This registry will collect long-term health and care data from people with mild cognitive impairment or dementia in Bavaria and their caregivers to understand how dementia progresses and how care is provided.
-
Hyperspectral retinal imaging to detect Alzheimer’s and other neurodegenerative changes
This project will test whether a special retinal camera that scans many wavelengths of light can detect signs of Alzheimer’s and other neurodegenerative diseases in people with dementia or at risk.
-
Can QSM MRI help tell MS from age-related brain changes in older adults
This study tests whether an advanced MRI technique called QSM can better differentiate MS-related brain lesions from age-related or small vessel changes in people aged 50–70.
-
Polyphenol-rich Salicornia plus B vitamins to slow cognitive decline after lacunar stroke
This will test whether a Salicornia-derived polyphenol supplement combined with B vitamins can slow thinking and memory decline in people who had a lacunar stroke within the past year.
-
Registry for people with cerebral small vessel disease.
This project will collect clinical information and MRI scans from people aged 50 and older with MRI signs of cerebral small vessel disease to see how the condition relates to thinking, walking, and daily function over time.
-
What predicts emergency department visits in frail older adults
This project tests whether a blood marker (plasma pTau181) and signs of cerebrovascular damage can help predict which non-autonomous older adults will need to return to the emergency department within six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.